Summary of Key Points from the Conference Call Industry Overview - The methionine industry is experiencing significant supply disruptions due to a 17% decrease in Qatar's MG production and geopolitical conflicts, leading to a risk of natural gas supply interruptions for 30% of Europe's methionine production capacity. This shift is causing a global supply tilt towards China [1][2]. - The industry is characterized by an oligopolistic structure, with major players including Evonik, Adisseo, and New Hope, holding a combined market share of over 70% [1][5]. - Global nominal methionine capacity is approximately 2.5 million tons, while demand stands at around 1.7 million tons, indicating a long-term oversupply situation [1][5]. Price Dynamics - Methionine prices have surged from 17-19 CNY/kg to 31-34 CNY/kg, reflecting a price increase of 70%-80% driven by rising costs and geopolitical factors [1][6]. - The price increase is attributed to the rapid rise in upstream raw material costs, particularly sulfur, and the impact of geopolitical tensions [6]. Supply Chain and Demand - The downstream demand for methionine is robust, particularly in the livestock sector, where adding 0.2% methionine can reduce chicken production costs by over 20%. The expected annual compound growth rate for the industry is projected to be 5%-6% [1][3][4]. - The global methionine market is segmented, with the Americas being relatively stable and less affected by current geopolitical issues. However, the remaining global demand of approximately 1.4 million tons may heavily rely on Chinese production if European capacity is disrupted [7]. Company-Specific Insights New Hope - New Hope has a methionine production capacity of 520,000-530,000 tons, with strong cost control and expectations for incremental capacity growth [1][8]. Adisseo - Adisseo, a leading global methionine producer, has a total capacity of 710,000 tons, with significant production facilities in Nanjing and plans for a 150,000-ton project in Quanzhou, which may accelerate its timeline for completion [1][9]. Hebang Biotechnology - Hebang Biotechnology has developed a liquid methionine capacity of 70,000 tons, leveraging natural gas resources in the Sichuan-Chongqing region. The company is well-positioned to benefit from high price levels in the methionine market [1][10]. Geopolitical Impact - The volatility in the natural gas market, exacerbated by Middle Eastern conflicts, poses a significant risk to the methionine industry, particularly in Europe, where production is heavily reliant on natural gas and other oil-related raw materials [2][7]. Conclusion - The methionine industry is at a critical juncture, with supply chain disruptions and price volatility creating both challenges and opportunities for key players. The reliance on Chinese production capacity may increase, and companies with strong cost control and production capabilities are likely to benefit in the current market environment [1][2][7].

Investment Rating - The report maintains an "Optimistic" rating for the chemical industry [3][4]. Core Insights - High oil prices are expected to sustain, leading to expanded arbitrage opportunities in coal chemical and natural gas chemical sectors. The price of methionine continues to rise due to strong demand, and positive feedback from the CAC Agricultural Exhibition is noted [3][4]. - The report suggests focusing on companies such as Baofeng Energy, Hualu Hengsheng, Luxi Chemical, Satellite Chemical, and Wanhua Chemical due to favorable market conditions [3][4]. Summary by Sections Macro Economic Judgments - Oil prices are likely to remain high due to geopolitical tensions affecting supply routes. Coal prices are stabilizing at a low point, while natural gas prices are expected to rise temporarily due to conflicts, with potential for reduced import costs as the U.S. accelerates natural gas export facility construction [3][4]. Chemical Sector Configuration - The report highlights the expansion of arbitrage opportunities in coal and natural gas chemicals, with natural gas arbitrage space at $12.11 per million British thermal units and coal arbitrage at 844 RMB per ton, both showing significant increases since the beginning of the year [3][4]. - The report emphasizes the importance of the agricultural chemical chain, with steady growth in fertilizer demand and rising prices for various pesticide products due to supply tightness and seasonal demand [3][4]. Investment Analysis - The report recommends a diversified investment strategy focusing on four areas: alternative energy (coal and natural gas chemicals), agricultural chemicals, fine chemicals with high overseas production ratios, and sectors with improving supply-demand dynamics [3][4]. - Specific companies to watch include Xinjiang Tianye and Wanwei High-tech in the PVA sector, and Yangnong Chemical and Anpon in the agricultural chemicals sector [3][4]. Key Material Focus - The report identifies key materials for growth, including semiconductor materials, OLED panel materials, and lithium battery materials, suggesting companies like Yake Technology and Dinglong Co. for investment opportunities [3][4].

Group 1 - Wanhua Chemical (600309) is a global leader in the polyurethane industry, with core businesses covering MDI, TDI, and polyether polyols, while also extending into petrochemicals, new materials, and fine chemicals. The company has established a comprehensive industrial chain from raw materials to end products, maintaining a leading market share in MDI due to its scale and technological barriers. It is expanding into high-performance materials and new energy materials, aligning with the trends in new energy and high-end manufacturing, which opens up long-term growth opportunities [1][25] - Juhua Co., Ltd. (600160) is a leading enterprise in the domestic fluorochemical sector, with core businesses including fluorochemicals, chlor-alkali chemicals, and petrochemical materials. The company has a significant capacity in fluorinated refrigerants and is expanding into electronic chemicals and photovoltaic fluorinated materials, gradually breaking through overseas technological monopolies. Its comprehensive layout in the fluorochemical industry chain and strong compliance and cost advantages position it well for growth [2][26] - Satellite Chemical (002648) is a leader in the domestic acrylic acid and ester industry, focusing on acrylic acid, high polymer emulsions, and functional polymer materials. The company is accelerating its layout in photovoltaic-grade EVA and POE new energy materials, leveraging its propane dehydrogenation process to build an integrated industrial chain. Its strong cost control and alignment with the growth of the photovoltaic and lithium battery industries provide sustainable development momentum [3][27] Group 2 - Hoshine Silicon Industry (603260) is a global leader in industrial silicon and organic silicon, with core businesses covering industrial silicon, organic silicon, and graphite electrodes. The company has a leading production capacity in industrial silicon and a comprehensive product range in organic silicon, benefiting from energy-rich production bases. Its complete industrial chain layout and focus on high-purity silicon for photovoltaics align with trends in new energy and high-end manufacturing, offering significant long-term growth potential [4][28] - Adisseo (600299) is a global leader in animal nutrition additives, with core products including methionine and vitamins widely used in livestock farming. The company has established a stable supply system and significant technological and cost advantages, while also expanding into biotechnology and functional food sectors. Its stable performance and low sensitivity to macroeconomic fluctuations enhance its competitive position in the global feed additive industry [5][29] - Zhejiang Longsheng (600352) is a global leader in the dye industry, with core businesses covering dyes, intermediates, and water-reducing agents. The company has a leading market share in disperse and reactive dyes, supported by an integrated industrial chain and strong cost control. Its diversified business structure enhances risk resilience, while its expansion into hydrogen energy and environmental protection projects strengthens its competitive position in the global dye and fine chemical industry [6][30] Group 3 - Haohua Technology (600378) is a domestic leader in high-end fluorinated materials and electronic chemicals, with core businesses including fluororesins, fluororubbers, and electronic-grade chemicals. The company benefits from deep technological reserves and has achieved some degree of import substitution. Its focus on high-end chemical materials aligns with national strategic emerging industries, providing long-term growth support [7][31] - Sanmei Co., Ltd. (603379) is a key player in the domestic fluorochemical sector, focusing on refrigerants, foaming agents, and fluorinated salts. The company has established an integrated fluorochemical industrial chain and is expanding into environmentally friendly refrigerants. Its stable cash flow and strong downstream demand support its competitive position in the domestic fluorochemical market [8][32] - Meihua Biological (600873) is a global leader in the amino acid industry, with core products including monosodium glutamate and amino acids widely used in food, feed, and pharmaceuticals. The company has a leading market share in MSG and lysine, supported by its advanced fermentation technology and cost advantages. Its expansion into pharmaceutical-grade amino acids and biodegradable materials enhances its competitive position in the global amino acid and fermentation industry [9][33]

证券代码：600299 证券简称：安迪苏 公告编号：2026-017 蓝星安迪苏股份有限公司 关于签订募集资金专户存储四方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意蓝星安迪苏股份有限公司向 特定对象发行股票注册的批复》（证监许可﹝2025﹞1970号），蓝星安迪苏股份有 限公司（以下简称"公司"）向特定对象发行人民币普通股（A股）397,877,984 股，发行价格为7.54元/股，募集资金总额为2,999,999,999.36元，上述募集资金， 扣除与募集资金相关的发行费用总计人民币16,124,892.90元（不含增值税），募 集资金净额为人民币2,983,875,106.46元。 本次募集资金已于2025年12月11日全部到账，并由毕马威华振会计师事务所 （特殊普通合伙）对本次发行的募集资金到位情况进行了审验，出具了《蓝星安 迪苏股份有限公司验资报告》（毕马威华振验字第2500758号）。 上述监管协议（以下简称本协议）主要内容如下： ...

Core Insights - The report highlights the implementation of a more proactive fiscal policy in China, emphasizing the importance of expanding domestic demand and optimizing economic structure for 2026 [2] - The energy sector shows a positive trend with a 6.1% year-on-year increase in total electricity consumption in the first two months of 2026, indicating robust industrial activity [2] - The report identifies key companies in various sectors, including banking, technology, and food, as potential investment opportunities [4] Company-Specific Summaries Andy Su (安迪苏) - In 2025, Andy Su achieved a revenue of 17.23 billion yuan, reflecting a year-on-year growth of 10.92%, while net profit decreased by 4.13% to 1.155 billion yuan [8] - The functional products segment saw a revenue increase of 11.12% to 12.914 billion yuan, driven by strong sales of liquid methionine [9] - The company is expanding its methionine production capacity, with significant projects nearing completion, which will help maintain its leading position in the global market [10] - Profit forecasts for 2026-2028 are adjusted, with expected net profits of 1.454 billion, 1.682 billion, and 1.864 billion yuan, corresponding to P/E ratios of 30, 26, and 24 times [11] Shandong Pharmaceutical Glass (山东药玻) - In 2025, Shandong Pharmaceutical Glass reported a revenue of 4.474 billion yuan, down 8.78% year-on-year, with net profit declining by 26.87% to 690 million yuan [13] - The decline in revenue is attributed to weak industry demand, influenced by healthcare payment reforms and centralized procurement [15] - The company improved its gross margin to 33.31%, aided by cost reductions in raw materials and enhanced automation [16] - Future profit projections for 2026-2028 are set at 762 million, 859 million, and 1.011 billion yuan, with corresponding P/E ratios of 17, 15, and 13 times [19]

1. Report Industry Investment Rating - No information provided in the given content 2. Core View of the Report - The tense situation in the Middle East has caused high - level fluctuations in oil prices, which in turn drives up the overall prices of chemical products [1] 3. Summary by Relevant Catalogs 3.1 Basic Chemical Weekly Data Briefing 3.1.1 Related Company Performance Tracking - The Basic Chemical Index had a 0.6% increase in the past week, 5.4% in the past month, 27.1% in the past three months, 49.5% in the past year, and 19.2% since the beginning of 2026 [8] - Among related companies, the stock prices of Baofeng Energy had significant increases, with a 21.2% increase in the past week, 44.6% in the past month, 95.6% in the past three months, 112.9% in the past year, and 76.8% since the beginning of 2026; while Wanhua Chemical's stock price decreased by 9.1% in the past week [8] 3.1.2 Related Company Profit Tracking - The total market value, net profit attributable to the parent company, PE, and PB of companies such as Wanhua Chemical, Baofeng Energy, Satellite Chemical, Hualu Hengsheng, New Hope Liuhe, and Adisseo were presented, with some data being the forecasts of Soochow Securities Research Institute [8] 3.1.3 Industry Chain Data - **Polyurethane Industry Chain**: The weekly average prices of pure MDI, polymer MDI, and TDI were 20457 yuan/ton, 16500 yuan/ton, and 17996 yuan/ton respectively, with month - on - month increases of 2114 yuan/ton, 1893 yuan/ton, and 2283 yuan/ton respectively; the corresponding gross profits were 5175 yuan/ton, 2218 yuan/ton, and 4510 yuan/ton, with month - on - month changes of +576 yuan/ton, +355 yuan/ton, and - 33 yuan/ton respectively [2][8] - **Oil - Gas - Olefin Industry Chain**: The average prices of ethane, propane, steam coal, and naphtha were 1250 yuan/ton, 6376 yuan/ton, 520 yuan/ton, and 6435 yuan/ton respectively, with month - on - month increases of 44 yuan/ton, 887 yuan/ton, 0 yuan/ton, and 1211 yuan/ton respectively. The average price of polyethylene was 8865 yuan/ton, with a month - on - month increase of 1215 yuan/ton; the theoretical profits of ethane cracking, CTO, and naphtha cracking to produce polyethylene were 1997 yuan/ton, 2556 yuan/ton, and - 1426 yuan/ton respectively, with month - on - month changes of +753 yuan/ton, +793 yuan/ton, and - 383 yuan/ton respectively. The average price of polypropylene was 8910 yuan/ton, with a month - on - month increase of 1640 yuan/ton; the theoretical profits of PDH, CTO, and naphtha cracking to produce polypropylene were - 781 yuan/ton, 2798 yuan/ton, and - 1028 yuan/ton respectively, with month - on - month changes of +306 yuan/ton, +1088 yuan/ton, and - 89 yuan/ton respectively [2][8] - **Coal - Chemical Industry Chain**: The average prices of synthetic ammonia, urea, DMF, and acetic acid were 2087 yuan/ton, 1839 yuan/ton, 5114 yuan/ton, and 2767 yuan/ton respectively, with month - on - month increases of 62 yuan/ton, 21 yuan/ton, 1005 yuan/ton, and 191 yuan/ton respectively; the corresponding gross profits were 88 yuan/ton, 154 yuan/ton, 428 yuan/ton, and 383 yuan/ton, with month - on - month increases of 63 yuan/ton, 5 yuan/ton, 169 yuan/ton, and 4 yuan/ton respectively [2][10] - **Animal Nutrition Industry Chain**: The average prices of VA, VE, solid methionine, and liquid methionine were 64.9 yuan/kg, 73.1 yuan/kg, 31.6 yuan/kg, and 19.0 yuan/kg respectively, with month - on - month increases of 4.4 yuan/kg, 9.7 yuan/kg, 10.7 yuan/kg, and 3.3 yuan/kg respectively [2][10] 3.2 Basic Chemical Weekly Report 3.2.1 Basic Chemical Index Trend - No detailed data provided in the given content 3.2.2 Polyurethane Plate - Analyzed the price trends and price - spread situations of pure MDI, polymer MDI, and TDI in China [15][18] 3.2.3 Oil - Gas - Olefin Plate - Studied the price trends of MB ethane, NYMEX natural gas, domestic steam coal, naphtha, crude oil, and propane, as well as the profitability of different processes such as ethane cracking to produce PE, PDH to produce PP, coal - to - PE, coal - to - PP, and naphtha - to - PE/PP [22][23][26][28][29][34][36][37] 3.2.4 Coal - Chemical Plate - Analyzed the price and gross - profit trends of coal - coking products (coking coal, coke), traditional coal - chemical products (synthetic ammonia, methanol, urea, DMF, acetic acid), and new materials (DMC, oxalic acid, octanol, adipic acid, caprolactam, PA6, PA66) [10][39][40][42][46][48][51][53] 3.2.5 Animal Nutrition Plate - Studied the price trends of VE, solid methionine, and liquid methionine [54][56]

中信证券股份有限公司 关于蓝星安迪苏股份有限公司 2025年度持续督导报告书 | 上市公司：蓝星安迪苏股份有限公司（以下简称"安迪苏""公司"） | | | --- | --- | | 保荐人名称：中信证券股份有限公司（以下简称"中信证券"或"保荐人"） | | | 保荐代表人姓名：潘杰克 | 联系电话：010-60834643 | | 保荐代表人姓名：黄艺彬 | 联系电话：010-60834643 | 经中国证券监督管理委员会《关于同意蓝星安迪苏股份有限公司向特定对象 发行股票注册的批复》（证监许可〔2025〕1970 号）核准，并经上海证券交易 所同意，公司向特定对象发行人民币普通股（A 股）397,877,984 股，每股发行 价格人民币 7.54 元，募集资金总额为 3,000,000,000.00 元，扣除各类发行费用之 后实际募集资金净额 2,983,875,106.46 元。毕马威华振会计师事务所（特殊普通 合伙）于 2025 年 12 月 15 日对蓝星安迪苏股份有限公司本次发行的募集资金到 位情况进行了验证，并出具了"毕马威华振验字第 2500758 号"验资报告。本次 向特定对象发行股票于 ...

中信证券股份有限公司 根据《上海证券交易所上市公司自律监管指引第 11 号——持续督导》等有 关法律、法规的规定，中信证券股份有限公司（以下简称"中信证券"或"保荐 人"）作为正在对蓝星安迪苏股份有限公司（以下简称"安迪苏""公司""上市 公司"）进行持续督导工作的保荐人，对 2025 年度（以下简称"本持续督导期间"） 的规范运作情况进行了现场检查，现就现场检查的有关情况报告如下： 一、本次现场检查的基本情况 （一）保荐人 中信证券股份有限公司 关于蓝星安迪苏股份有限公司 2025 年度持续督导工作现场检查报告 （二）保荐代表人 潘杰克、黄艺彬 （三）现场检查人员 潘杰克 （四）现场检查时间 2026 年 3 月 6 日 （五）现场检查内容 现场检查人员对本持续督导期内发行人公司治理和内部控制情况、信息披露 情况、公司的独立性以及与控股股东、实际控制人及其他关联方资金往来情况、 募集资金使用情况、关联交易、对外担保、重大对外投资情况、经营状况等方面 进行了现场检查，具体检查内容详见本报告"二、本次现场检查主要事项及意见"。 （六）现场检查手段 1 本次现场检查的手段主要包括资料查阅、访谈、现场查看等，具体检 ...

Investment Rating - The report maintains a "Strong Buy" rating for the company [2][5]. Core Insights - The company achieved a revenue of 17.231 billion yuan in 2025, representing a year-on-year growth of 10.92%, while the net profit attributable to shareholders was 1.155 billion yuan, down 4.13% year-on-year [3]. - The functional products segment saw a revenue increase of 11.12% to 12.914 billion yuan, driven by strong sales of liquid methionine, which reached a historical record in global market penetration [3]. - The special products segment also performed well, with a revenue increase of 10.31% to 4.316 billion yuan, particularly in North America and Europe, where sales of ruminant products grew over 20% [3]. - The company has implemented an "Operational Efficiency Improvement Plan" since 2019, which has helped reduce regular operating costs by 230 million yuan, showcasing strong cost competitiveness [3]. - The company is expanding its methionine production capacity, with significant projects underway, including a 150,000-ton solid methionine plant in Quanzhou, expected to start trial operations by the end of 2026 [4]. Financial Performance Summary - The company forecasts net profits of 1.454 billion yuan, 1.682 billion yuan, and 1.864 billion yuan for 2026, 2027, and 2028, respectively, with corresponding EPS of 0.47 yuan, 0.55 yuan, and 0.61 yuan [5]. - The projected revenue growth rates for the next few years are 8.50% for 2026, 9.75% for 2027, and 10.50% for 2028 [6]. - The comprehensive gross margin decreased by 1.90 percentage points to 28.31% [3].

Investment Rating - The report maintains a "Strong Buy" rating for the company [2][5]. Core Insights - The company achieved a revenue of 17.231 billion yuan in 2025, representing a year-on-year growth of 10.92%, while the net profit attributable to shareholders was 1.155 billion yuan, down 4.13% year-on-year [3]. - The functional products segment saw a revenue increase of 11.12% to 12.914 billion yuan, driven by strong sales of liquid methionine, which reached a historical record in global market penetration [3]. - The special products segment also grew by 10.31% to 4.316 billion yuan, with significant sales growth in ruminant products in North America and Europe, particularly the Stemin product line, which grew over 20% [3]. - The company has implemented an "Operational Efficiency Improvement Plan" since 2019, which has helped reduce regular operating costs by 230 million yuan, showcasing strong cost competitiveness [3]. Financial Performance - The company forecasts net profits of 1.454 billion yuan, 1.682 billion yuan, and 1.864 billion yuan for 2026, 2027, and 2028, respectively, with corresponding EPS of 0.47, 0.55, and 0.61 yuan [5][6]. - The projected P/E ratios for 2026, 2027, and 2028 are 30, 26, and 24 times, respectively [5][6]. - The comprehensive gross margin decreased by 1.90 percentage points to 28.31% [3]. Capacity Expansion and Market Position - The company is expanding its methionine production capacity, with a solid methionine plant in Quanzhou, Fujian, expected to start trial operations by the end of 2026, and a liquid methionine plant in Spain nearing full production capacity [4]. - The ongoing expansion of methionine capacity and excellent operational performance of major plants will support further increases in methionine product sales [4]. - The company's dual production platforms in China and Europe allow for flexible supply adjustments and optimization of global supply costs [4].